Introduction
============

Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia and dysfunctional glucose and lipid metabolism that results from insufficient or defective insulin secretion, insulin resistance, or both \[[@b1-cerm-2019-03251]\]. DM can exert destructive effects on multiple organs in the body, and especially on male infertility \[[@b2-cerm-2019-03251]\]. DM and metabolic syndrome aﬀect sperm quality and function and may cause retrograde ejaculation and hypogonadism \[[@b3-cerm-2019-03251]\]. Furthermore, DM can interrupt the endocrine control of spermatogenesis \[[@b4-cerm-2019-03251]\].

Insulin resistance and/or impaired insulin secretion in DM results in the overproduction of reactive oxygen species (ROS), leading to oxidative stress that triggers diabetic complications \[[@b5-cerm-2019-03251]\]. It has been reported that spermatozoa are susceptible to oxidative stress-induced damage \[[@b6-cerm-2019-03251]\]. Previous studies have shown that men with DM have a higher proportion of spermatozoa with nuclear DNA damage, resulting in alterations of male fertility, patterns of early embryonic growth, reproductive outcomes, and miscarriage rates \[[@b7-cerm-2019-03251]-[@b10-cerm-2019-03251]\]. Since oxidative stress damages spermatozoa, antioxidants and medicinal herbs play an important role in the maintenance of sperm motility and sperm DNA integrity in the face of oxidative damage \[[@b11-cerm-2019-03251]-[@b13-cerm-2019-03251]\]. Plants have always been an exemplary source of drugs, and many currently available drugs have been derived from plants.

*Commiphora mukul* (in the Burseraceae family), commonly known as gum guggulu, has been used for over 2,500 years as a valued herb in Ayurvedic Medicine, a system of South Asian Medicine practiced in India, Bangladesh, and Pakistan. Bellamkonda et al. \[[@b14-cerm-2019-03251]\] reported the antihyperglycemic and antioxidant activities of an alcoholic extract of *C. mukul* gum resin in streptozotocin (STZ)-induced diabetic rats. *C. mukul* has the potential to promote health in individuals with DM and many other diseases through its anti-inflammatory, hypoglycemic, antihyperlipidemic, and antioxidant effects \[[@b14-cerm-2019-03251],[@b15-cerm-2019-03251]\].

Given the antioxidant effects of *C. mukul* and the fact that DM is associated with enhanced oxidative stress and diminished antioxidant status, our hypothesis was that *C. mukul* would act as a protective factor against the negative consequences of DM. The strong antioxidant activity of *C. mukul* prompted us to design the present study to explore whether treatment with *C. mukul* extract (CME) would have any protective influence on sperm parameters, testosterone levels, and plasma glucose levels in STZ-induced diabetic rats.

The following MeSH terms for *C. mukul* were used in our search of the literature: Commiphora molmol, Commiphora wightii, Commiphora myrrha, Commiphora molmol, Common Myrrh Tree, Myrrh Tree, Common Tree, Common Myrrh, Guggul Tree, Commiphora erythraea, Myrrh, Bisabol, Commiphora kataf, Bisabol Myrrh, and Guggul.

Methods
=======

1. Ethics statement
-------------------

All experimental procedures using rats were conducted in accordance with the Animal Care and Use Guidelines approved by the Institutional Ethics Committee of Hamadan University of Medical Sciences and were performed in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals \[[@b16-cerm-2019-03251]\]. All efforts were made to minimize suffering. Operations that could cause pain and distress were performed in a separate room in the absence of other animals.

2. Animals and experimental design
----------------------------------

Adult male Wistar rats weighing 220±10 g were obtained from the Pasteur Institute of Tehran, Iran. The animals were housed in an airconditioned room at 22°C±2°C with a 12-hour light/dark cycle. The animals were kept in cages with 2--3 rats in each cage. Standard animal chow and water were freely available. After 1 week of adaptation, the subjects were randomly divided into four groups: control, control animals treated with CME (300 mg/kg), diabetic animals, and diabetic animals treated with CME (300 mg/kg). The oral dosage of CME was selected based on our previous work \[[@b17-cerm-2019-03251]\], in light of the finding that a dose of less than 200 mg/kg body weight is not expected to be effective in rats \[[@b14-cerm-2019-03251]\]. All rats had free access to food and tap water. Saline or CME was administered for 60 days by daily gavage through gastric intubation using a syringe once daily at 8:00 AM. The experimental design of this study is presented in [Figure 1](#f1-cerm-2019-03251){ref-type="fig"}.

3. Induction of diabetes
------------------------

Diabetes was induced by an intraperitoneal injection of 50 mg/kg STZ (Sigma, St. Louis, MO, USA), which was dissolved in freshly prepared 0.05 M citrate buffer (pH 4.5) immediately before injection \[[@b18-cerm-2019-03251],[@b19-cerm-2019-03251]\]. Blood glucose concentrations were monitored once per week. A minimum blood glucose level of \>250 mg/dL and the presence of urinary glucose were used as criteria to identify diabetic rats. Age-matched, vehicle-treated rats were used as controls. Serum fasting blood glucose concentrations were measured using the glucose oxidase method (Pars Azmoon kits; Tehran, Iran); the intra- and interassay coefficients of variation were 2.5% and 6.1%, respectively \[[@b20-cerm-2019-03251]\].

4. Preparation of ethanolic extract of *C. mukul*
-------------------------------------------------

An ethanolic extract of *C. mukul* gum resin was obtained from the manufacturers and exporters of herbal extracts. The following procedure was used to prepare the extract: the collected plant sample (resin) was washed thoroughly with tap water, dried at room temperature away from sunlight, cut into small pieces, and then powdered. Ethanolic extract was prepared by cold maceration of gum resin powder in ethanol for 7 days. The extract was filtered, concentrated under reduced pressure, and finally dried in a vacuum desiccator. The extract was stored at 0°C--4°C and dissolved in water just before use \[[@b21-cerm-2019-03251]\].

5. Epididymal sperm count, weight, motility, morphology, and viability
----------------------------------------------------------------------

### 1) Sperm collection and sperm count

A laparotomy was performed to expose the reproductive tract. Testis weight and the ratio of testis weight to body weight were determined. The left and right epididymis were carefully separated from the testis and placed in a Petri dish containing Ham's F10 medium. The epididymides were minced with scissors to release sperm and were then placed in an incubator for 15 minutes. Approximately 10 μL of the diluted sperm suspension was transferred to each counting chamber of the hemocytometer and allowed to stand for 5 minutes. The cells that settled during this time were counted under light microscopy at ×200 magnification. The sperm heads were counted and expressed as millions/mL of suspension \[[@b22-cerm-2019-03251]\].

### 2) Sperm morphology

Sperm morphology was also characterized using eosin and nigrosin staining as described elsewhere \[[@b23-cerm-2019-03251],[@b24-cerm-2019-03251]\]. To a test tube containing 40 μL of sperm suspension, 10 μL of 1% eosin Y and nigrosin was added and mixed by gentle agitation. Sperm were incubated at room temperature for 45--60 minutes for staining and then re-suspended with a Pasteur pipette. It is preferable to examine 200 sperm per animal at ×400--1,000 magnification for morphological analyses. Morphological abnormalities were classified as follows: headless sperm, flattened head (reduced hook, banana head, pin, or nail), bent neck, bent tail, kinked tail, or multiple abnormalities \[[@b24-cerm-2019-03251]\].

### 3) Sperm motility

Spermatozoa were classified as motile or immotile. Aliquots of the sperm suspension prepared for analysis were placed on a slide. The slides were evaluated with phase contrast microscopy in 10 microscopic fields, and 200 sperm per animal were analyzed at a final magnification of ×1,000. The motile sperm fraction was defined as the mean number of motile sperm ×100, divided by the total number of sperm \[[@b23-cerm-2019-03251]\].

### 4) Sperm viability

Sperm viability was also determined by using eosin staining (Sigma Aldrich, St. Louis, MO, USA) as described previously \[[@b24-cerm-2019-03251]\]. Eosin penetrates non-viable, dead spermatozoa with disrupted membranes, which stain red using this technique. The percentage of normal morphology per 100 spermatozoa for each rat was assessed under light microscopy (×400; Zeiss, Munich, Germany) as described previously \[[@b22-cerm-2019-03251],[@b24-cerm-2019-03251]\]. An experienced technician blinded to the study performed all analyses.

6. Serum testosterone measurements
----------------------------------

After blood collection from the heart, specimens were centrifuged. Then, the serum concentration of testosterone was measured using an enzyme-linked immunosorbent assay kit for testosterone (Demeditec, Kiel, Germany) \[[@b13-cerm-2019-03251]\]. The sensitivity of hormone detection in each assay tube was 0.066 ng/mL.

7. Statistical analysis
-----------------------

All data are presented as mean±standard error of the mean. Statistical analyses were performed using GraphPad Prism (v. 8.0; Graph-Pad Software, La Jolla, CA, USA). The distribution of data was normal when examined using the Kolmogorov-Smirnov test. One-way analysis of variance (ANOVA) was performed, followed by the Tukey test for multiple comparisons. A *p*-value of 0.05 was considered as the criterion for significance.

Results
=======

1. Effects of DM and CME on blood glucose
-----------------------------------------

Mean blood glucose levels were analyzed before and after the STZ injection and at the end of experiment ([Figure 2](#f2-cerm-2019-03251){ref-type="fig"}). Before the STZ injection, there was no significant difference among the experimental groups of rats (F\[[@b3-cerm-2019-03251], [@b16-cerm-2019-03251]\]=0.833, *p*=0.495, one-way ANOVA). After the STZ injection, the mean blood glucose levels in the DM and DM+CME groups were significantly higher than in the control group (F\[[@b3-cerm-2019-03251], [@b16-cerm-2019-03251]\]=130.1, *p*\<0.001, one-way ANOVA).

At the end of the experimental period, venous blood was collected from all rats and mean blood glucose levels were analyzed (F\[[@b3-cerm-2019-03251], [@b16-cerm-2019-03251]\]=178.7, *p*\<0.001, one-way ANOVA\]. Our results showed that CME supplementation decreased blood glucose levels in animals with DM (*p*\<0.05). The results are summarized in [Figure 2](#f2-cerm-2019-03251){ref-type="fig"}.

2. Effects of DM and CME on testis weight and the ratio of testis weight to body weight
---------------------------------------------------------------------------------------

[Figure 3](#f3-cerm-2019-03251){ref-type="fig"} shows the eﬀect of DM and CME treatment on testis weight and the ratio of testis weight to body weight. Significant differences were found among the experimental groups. The final body weight was significantly different among the experimental groups (F\[[@b3-cerm-2019-03251], [@b16-cerm-2019-03251]\]=440.1, *p*\<0.001, one-way ANOVA). [Figure 3A](#f3-cerm-2019-03251){ref-type="fig"} shows the final body weight of the rats in each group. The body weight of all diabetic animals was significantly lower than the body weight of the control group (*p*\<0.001). The DM+CME group demonstrated a higher final body weight than the DM group (*p*\<0.01), and also exhibited more weight gain than the DM group. [Figure 3B](#f3-cerm-2019-03251){ref-type="fig"} shows the testis weight of the rats in each group. Testis weight was significantly different among the experimental groups (F\[[@b3-cerm-2019-03251], [@b16-cerm-2019-03251]\]=400.2, *p*\<0.001, one-way ANOVA). The DM group exhibited lower testis weight than the control group (*p*\<0.001). In the DM+CME group, testis weight was higher than that of the DM animals without CME (*p*\<0.01). The ratio of testis weight to body weight did not significantly differ among the experimental groups (*p*\>0.05) ([Figure 3C](#f3-cerm-2019-03251){ref-type="fig"}). The results are summarized in [Figure 3](#f3-cerm-2019-03251){ref-type="fig"}.

3. Effects of DM and CME on sperm parameters
--------------------------------------------

[Figure 4](#f4-cerm-2019-03251){ref-type="fig"} shows the eﬀects of DM and CME treatment on epididymal sperm characteristics. The total sperm count extracted from the epididymis decreased significantly in diabetic animals compared with the control group (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=10.01, *p*=0.001, one-way ANOVA) ([Figure 4A](#f4-cerm-2019-03251){ref-type="fig"}). Treatment of diabetic animals with CME increased the total sperm count in the DM animals (*p*\<0.05). Sperm viability decreased significantly in the DM group in comparison with the control group (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=3.062, *p*=0.044, one-way ANOVA) ([Figure 4B](#f4-cerm-2019-03251){ref-type="fig"}). There was no significant difference between the control group and the DM + CME animals (*p*\>0.05).

The percentage of sperm with normal morphology was lower in the animals with DM than in the control animals (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=4.756, *p*=0.008, one-way ANOVA) ([Figure 4C](#f4-cerm-2019-03251){ref-type="fig"}). In addition, the proportion of sperm with abnormal morphology was higher in the animals with DM than in the control animals (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=4.750, *p*=0.008, one-way ANOVA) ([Figure 4C](#f4-cerm-2019-03251){ref-type="fig"}). The proportion of sperm with abnormal morphology was lower in the DM+CME group than in the DM group (*p*\<0.05).

[Figure 4D](#f4-cerm-2019-03251){ref-type="fig"} shows that sperm motility was significantly different among the groups (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=15.32, *p*\<0.001, one-way ANOVA\]. DM reduced sperm motility (*p*\<0.001) and CME supplementation partially reversed this effect (*p*=0.003). Moreover, the percentage of immotile sperm was higher in the animals with DM (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=14.75, *p*\<0.001, one-way ANOVA) ([Figure 4E](#f4-cerm-2019-03251){ref-type="fig"}). Treatment of diabetic animals with CME decreased the proportion of immotile sperm (*p*\< 0.001). Furthermore, forward movement was reduced in the DM group (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=8.963, *p*\<0.001, one-way ANOVA) ([Figure 4F](#f4-cerm-2019-03251){ref-type="fig"}). All results are summarized in [Figure 4](#f4-cerm-2019-03251){ref-type="fig"}.

4. Effects of DM and CME on blood testosterone levels
-----------------------------------------------------

The mean serum testosterone levels in the DM and control animals were 0.7±0.2 and 1.75±0.2 ng/mL, respectively. Thus, it was clear that DM in rats caused a significant decrease (*p*\<0.05) in serum testosterone levels compared to the control group (F\[[@b3-cerm-2019-03251], [@b28-cerm-2019-03251]\]=3.283, *p*=0.035, one-way ANOVA) ([Figure 5](#f5-cerm-2019-03251){ref-type="fig"}). However, there was no significant difference between the DM+CME group and the control animals (*p*=0.995).

Discussion
==========

This study was undertaken to investigate whether CME could attenuate the negative effects of DM on sperm parameters, testosterone levels, and plasma glucose levels in STZ-induced diabetic rats. Sperm motility, count, and viability were significantly lower in diabetic animals than in the control group. We also showed that the rates of morphological abnormalities in sperm were considerably higher in diabetic animals. However, CME-treated diabetic rats had significantly higher proportions of normal sperm morphology, motility, count, and viability than non-CME-treated diabetic rats. Moreover, *C. mukul* attenuated the adverse effects of DM on testosterone levels. In addition, *C. mukul* supplementation decreased blood glucose levels in diabetic animals.

In accordance with our results, it has been shown that DM and hyperglycemia pose a threat to spermatozoa function and can increase the risk of infertility \[[@b25-cerm-2019-03251],[@b26-cerm-2019-03251]\]. The impact of DM on the male reproductive system may be due to its effects on endocrine control of spermatogenesis, steroidogenesis, sperm maturation, and penile erectile dysfunction \[[@b27-cerm-2019-03251]\].

Insulin resistance and/or impaired insulin secretion in DM result in hyperglycemia. Persistent hyperglycemia induces the overproduction of ROS, the formation of advanced glycation end products, secretion of proinflammatory cytokines and cellular death, and, consequently, diabetic complications \[[@b5-cerm-2019-03251]\]. Karimi et al. \[[@b28-cerm-2019-03251]\] showed that increased ROS production altered sperm parameters and increased sperm nuclear DNA fragmentation. Shrilatha et al. \[[@b29-cerm-2019-03251]\] also reported STZ-induced oxidative damage in the testis and epididymal sperm of mice.

Since oxidative damage leads to many problems, it has become increasingly common to use antioxidant agents and medicinal herbs to prevent and treat various types of diabetes-related disorders \[[@b12-cerm-2019-03251],[@b30-cerm-2019-03251],[@b31-cerm-2019-03251]\]. For example, Bahmanzadeh et al. \[[@b12-cerm-2019-03251]\] showed that dietary supplementation with astaxanthin may ameliorate sperm parameters and DNA integrity in STZ-induced diabetic rats.

Some bioactive compounds has been reported in CME, including dimyrcene; α-camphorene; linoleic, oleic, stearic, and palmitic acids; sitosterol; Z- and E-guggulsterone; and (8R)-3α,8-dihydroxypolypoda- 13E,17E,21-triene (myrrhanol C,4-pregnene-3,16-dione, 20S-acetyloxy-4-pregnene-3,16-dione, 4,17(20)-(*cis*)-pregnadiene- 3,16-dione, 4,17(20)-(*trans*)-pregnadiene-3,16-dione, 16 β-acetyloxy-pregn-4,17(20)-*trans*-dien-3-one, 3 α-acetyloxy-5α- pregnan-16-one, 20R,22R-dihydroxycholest-4-en-3-one) \[[@b32-cerm-2019-03251],[@b33-cerm-2019-03251]\]. Furthermore, several amino acids have been reported to be present in CME, including cystine, histidine, alanine, proline, tyrosine, tryptophan, valine, leucine, and isoleucine \[[@b33-cerm-2019-03251]\]. Commipheric acid, guggulipid (ethyl acetate extract of the gum of the guggul tree), and guggulsterone are the main components of *C. mukul* (guggul) \[[@b34-cerm-2019-03251]\]. Guggul is reported to have antidiabetic properties and it acts as a dual activator for peroxisome proliferator-activated receptors alpha and gamma (PPAR-α and PPAR-γ) \[[@b34-cerm-2019-03251],[@b35-cerm-2019-03251]\]. Guggulsterone has been reported to exert both hypoglycemic and hypolipidemic activity in high-fat diet-induced diabetic rats, and it may have therapeutic potential for type 2 DM \[[@b36-cerm-2019-03251]\]. Bellamkonda et al. \[[@b14-cerm-2019-03251]\] showed beneficial effects of ethanolic CME against high-fructose diet-induced abnormalities in carbohydrate and lipid metabolism in Wistar rats. They found that 60 days of *C. mukul* treatment completely prevented fructose- induced increased body weight, hyperglycemia, insulin resistance, and hypertriglyceridemia \[[@b37-cerm-2019-03251]\]. It has also been reported that ethanolic CME attenuated STZ-induced alterations in the activity of enzymes involved in glucose metabolism (hexokinase, phosphofructokinase, pyruvate kinase, glucose-6-phosphatase, fructose-1,6- bisphosphatase, and glucose-6-phosphate dehydrogenase) and lipid metabolism (fatty acid synthase, malic enzyme, and lipoprotein lipase) \[[@b21-cerm-2019-03251]\]. Ramesh et al. \[[@b38-cerm-2019-03251]\] showed that *C. mukul* played a preventive role against STZ-induced diabetic oxidative stress. They reported that the administration of *C. mukul* (200 mg/kg body weight) to diabetic rats for 60 days decreased the activity of aspartate aminotransaminase and alanine aminotransaminase in the liver and kidney and reduced the levels of oxidative markers such as lipid peroxidation and protein oxidation in the pancreas and heart.

CMEs have been extensively studied for their broad range of biological activities, especially related to their antioxidant properties. The antioxidant activity of an alcoholic extract of *C. mukul* gum resin in STZ-induced diabetic rats was reported by Ramesh et al. \[[@b38-cerm-2019-03251]\]. In addition, it has been shown that C. molmol attenuated oxidative stress in hyperammonemic rats \[[@b39-cerm-2019-03251]\]. It was found that *C. mukul* significantly lowered lipid peroxidation by maintaining the activity of the major antioxidant enzymes (superoxide dismutase, catalase and glutathione peroxide) in STZ-induced diabetic rats \[[@b14-cerm-2019-03251]\]. Cellular damage in semen is the result of an inappropriate balance between ROS production and scavenging activities. Extreme ROS generation that exceeds critical levels can overwhelm all the antioxidant defense strategies of spermatozoa and seminal plasma, causing oxidative stress \[[@b40-cerm-2019-03251],[@b41-cerm-2019-03251]\]. Because of the high content of polyunsaturated fatty acids in the plasma membrane, spermatozoa are highly sensitive to excessive concentrations of ROS. Lipid peroxidation destroys the structure of the lipid matrix in the sperm membrane, which is accompanied by a loss of motility and impaired spermatogenesis \[[@b42-cerm-2019-03251],[@b43-cerm-2019-03251]\].

In the present study, the administration of CME for 60 consecutive days significantly increased sperm motility and viability in diabetic animals. This increase in sperm motility and viability may have been due to the protective effects of *C. mukul*. No toxicity symptoms occur in response to chronic treatment with C. molmol \[[@b44-cerm-2019-03251]\]. Furthermore, it has been reported that C. molmol has androgenic potential \[[@b45-cerm-2019-03251]\], and based on our results, it attenuates the negative effects of diabetes on sperm parameters, testosterone levels, and plasma glucose levels in STZ-induced diabetic rats. Several plants have been found to affect serum testosterone and dihydrotestosterone levels \[[@b44-cerm-2019-03251]\]. Testosterone and related androgenic derivatives are essential for male fertility and the maintenance of spermatogenesis. In conclusion, the present study demonstrated that *C. mukul* possesses antioxidant and proandrogenic activities, enabling it to exert a beneficial effect on spermatogenesis and sperm parameters in rats.
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![Experimental design. After 1 week of adaptation, *Commiphora mukul (C. mukul)* extract (300 mg/kg) was administered intragastrically by gavage once a day for 60 days. Epididymal sperm parameters and biochemical parameters were then analyzed in male rats. STZ, streptozotocin.](cerm-2019-03251f1){#f1-cerm-2019-03251}
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![Sperm parameters: (A) sperm count, (B) viability, (C) morphology, (D) motility, (E) immotile sperm, and (F) forward movement in the experimental groups. Each column and bar represents mean ± standard error of the mean. CME, Commiphora mukul extract; DM, diabetes mellitus; NS, not significant. ^a)^*p*\< 0.05; ^b)^*p*\< 0.01; ^c)^*p*\< 0.001.](cerm-2019-03251f4){#f4-cerm-2019-03251}
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